GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinovac Biotech Ltd (NAS:SVA) » Definitions » Shiller PE Ratio

Sinovac Biotech (Sinovac Biotech) Shiller PE Ratio

: 0.82 (As of Today)
View and export this data going back to 2003. Start your Free Trial

As of today (2024-04-19), Sinovac Biotech's current share price is $6.47. Sinovac Biotech's E10 for the fiscal year that ended in Dec22 was $7.90. Sinovac Biotech's Shiller PE Ratio for today is 0.82.

The historical rank and industry rank for Sinovac Biotech's Shiller PE Ratio or its related term are showing as below:

SVA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 0.82   Med: 87.04   Max: 634
Current: 0.82

During the past 13 years, Sinovac Biotech's highest Shiller PE Ratio was 634.00. The lowest was 0.82. And the median was 87.04.

SVA's Shiller PE Ratio is not ranked
in the Biotechnology industry.
Industry Median: 32.205 vs SVA: 0.82

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sinovac Biotech's adjusted earnings per share data of for the fiscal year that ended in Dec22 was $1.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $7.90 for the trailing ten years ended in Dec22.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sinovac Biotech Shiller PE Ratio Historical Data

The historical data trend for Sinovac Biotech's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinovac Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.10 83.40 33.22 0.85 0.82

Sinovac Biotech Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.85 - 0.82 -

Competitive Comparison

For the Biotechnology subindustry, Sinovac Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinovac Biotech Shiller PE Ratio Distribution

For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sinovac Biotech's Shiller PE Ratio falls into.



Sinovac Biotech Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sinovac Biotech's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=6.47/7.9
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinovac Biotech's E10 for the fiscal year that ended in Dec22 is calculated as:

For example, Sinovac Biotech's adjusted earnings per share data for the fiscal year that ended in Dec22 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec22 (Change)*Current CPI (Dec22)
=1/115.1156*115.1156
=1.000

Current CPI (Dec22) = 115.1156.

Sinovac Biotech Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 0.130 97.624 0.153
201412 -0.030 99.000 -0.035
201512 -0.030 100.600 -0.034
201612 -0.010 102.600 -0.011
201712 0.450 104.500 0.496
201812 0.340 106.500 0.368
201912 0.410 111.200 0.424
202012 0.970 111.500 1.001
202112 74.270 113.108 75.588
202212 1.000 115.116 1.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sinovac Biotech  (NAS:SVA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Sinovac Biotech Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Sinovac Biotech's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinovac Biotech (Sinovac Biotech) Business Description

Traded in Other Exchanges
N/A
Address
No.39, Shangdi Xi Road, Haidan District, Beijing, CHN, 100085
Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.
Executives
Lily Wang director, 10 percent owner, officer: Chief Financial Officer 300 MURCHISON DR., MILLBRAE CA 94030
Ifg Investments Services Inc 10 percent owner PO BOX 822, CHARLESTOWN FEDERATION OF ST KITTS & NEVIS WEST INDIES P8 00000
Yin Weidong director, 10 percent owner, officer: President and CEO
Terry G Bowering director, 10 percent owner, officer: President, CEO 10 CEDAR MEADOW DRIVE REGINA A9 S4X 3J6

Sinovac Biotech (Sinovac Biotech) Headlines

From GuruFocus